Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2000, p. 7259-7272, Vol. 20, No. 19
Departments of
Microbiology1 and
Medicine2 and Ruttenberg Cancer
Center,3 Mount Sinai School of Medicine, New
York, New York 10029-6574
Received 8 February 2000/Returned for modification 20 June
2000/Accepted 5 July 2000
SSeCKS, first isolated as a G1
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
SSeCKS, a Major Protein Kinase C Substrate with Tumor
Suppressor Activity, Regulates G1
S Progression by
Controlling the Expression and Cellular Compartmentalization of
Cyclin D

S inhibitor that is
downregulated in src- and ras-transformed
cells, is a major cytoskeleton-associated PKC substrate with tumor
suppressor and kinase-scaffolding activities. Previous attempts at
constitutive expression resulted in cell variants with truncated
ectopic SSeCKS products. Here, we show that tetracycline-regulated
SSeCKS expression in NIH 3T3 cells induces G1 arrest marked
by extracellular signal-regulated kinase 2-dependent decreases in
cyclin D1 expression and pRb phosphorylation. Unexpectedly,
the forced reexpression of cyclin D1 failed to rescue SSeCKS-induced
G1 arrest. Confocal microscopy analysis revealed cytoplasmic colocalization of cyclin D1 with SSeCKS. Because the SSeCKS
gene encodes two potential cyclin-binding motifs (CY) flanking major in
vivo protein kinase C (PKC) phosphorylation sites
(Ser507/515), we addressed whether SSeCKS encodes a
phosphorylation-dependent cyclin scaffolding function. Bacterially
expressed SSeCKS-CY bound cyclins D1 and E, whereas K
S mutations
within either CY motif ablated binding. Activation of PKC in vivo
caused a rapid translocation of cyclin D1 to the nucleus. Cell
permeable, penetratin-linked peptides encoding wild-type SSeCKS-CY, but
not K
S or phospho-Ser507/515 variants, released cyclin
D1 from its cytoplasmic sequestration and induced higher saturation
density in cyclin D1-overexpressor cells or rat embryo
fibroblasts. Our data suggest that SSeCKS controls G1
S
progression by regulating the expression and localization of cyclin D1. These data suggest that downregulation of SSeCKS in tumor cells removes gating checkpoints for saturation density, an effect that may promote contact independence.
*
Corresponding author. Mailing address: Department of
Medicine and Ruttenberg Cancer Center, Mount Sinai School of Medicine, Box 1090, One Gustave L. Levy Place, New York, NY 10029-6574. Phone:
(212) 241-3749. Fax: (212) 828-4202. E-mail:
irwin.gelman{at}mssm.edu.
Present address: Joslin Diabetes Center, Harvard Medical School,
Boston, MA 02215.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|